GH
Price
$22.16
Change
+$0.36 (+1.65%)
Updated
Oct 4 closing price
25 days until earnings call
NVCR
Price
$14.72
Change
+$0.18 (+1.24%)
Updated
Oct 4 closing price
24 days until earnings call
Ad is loading...

GH vs NVCR

Header iconGH vs NVCR Comparison
Open Charts GH vs NVCRBanner chart's image
Guardant Health
Price$22.16
Change+$0.36 (+1.65%)
Volume$1.13M
CapitalizationN/A
NovoCure
Price$14.72
Change+$0.18 (+1.24%)
Volume$498.23K
CapitalizationN/A
View a ticker or compare two or three
GH vs NVCR Comparison Chart
Loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GH vs. NVCR commentary
Oct 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Buy and NVCR is a StrongSell.

COMPARISON
Comparison
Oct 07, 2024
Stock price -- (GH: $22.16 vs. NVCR: $14.72)
Brand notoriety: GH: Notable vs. NVCR: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 46% vs. NVCR: 53%
Market capitalization -- GH: $2.46B vs. NVCR: $1.66B
GH [@Medical Specialties] is valued at $2.46B. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, NVCR is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 3 TA indicator(s) are bullish.

  • NVCR’s TA Score: 3 bullish, 6 bearish.

Price Growth

GH (@Medical Specialties) experienced а -3.15% price change this week, while NVCR (@Medical Specialties) price change was -5.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.13%. For the same industry, the average monthly price growth was +4.30%, and the average quarterly price growth was -3.02%.

Reported Earning Dates

GH is expected to report earnings on Feb 20, 2025.

NVCR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-1.13% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than NVCR($1.66B). NVCR YTD gains are higher at: -1.407 vs. GH (-18.078). NVCR has higher annual earnings (EBITDA): -177.45M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. NVCR (911M). NVCR has less debt than GH: NVCR (596M) vs GH (1.35B). GH has higher revenues than NVCR: GH (564M) vs NVCR (509M).
GHNVCRGH / NVCR
Capitalization2.47B1.66B149%
EBITDA-433.3M-177.45M244%
Gain YTD-18.078-1.4071,285%
P/E RatioN/AN/A-
Revenue564M509M111%
Total Cash1.17B911M128%
Total Debt1.35B596M227%
FUNDAMENTALS RATINGS
GH vs NVCR: Fundamental Ratings
GH
NVCR
OUTLOOK RATING
1..100
669
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6362
P/E GROWTH RATING
1..100
10012
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (75) in the Medical Or Nursing Services industry is in the same range as NVCR (100) in the Medical Specialties industry. This means that GH’s stock grew similarly to NVCR’s over the last 12 months.

GH's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as NVCR (100) in the Medical Specialties industry. This means that GH’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (96) in the Medical Specialties industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that NVCR’s stock grew similarly to GH’s over the last 12 months.

NVCR's Price Growth Rating (62) in the Medical Specialties industry is in the same range as GH (63) in the Medical Or Nursing Services industry. This means that NVCR’s stock grew similarly to GH’s over the last 12 months.

NVCR's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that NVCR’s stock grew significantly faster than GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCR
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VVSCX12.800.16
+1.27%
VALIC Company I Small Cap Value
RNWHX85.040.63
+0.75%
American Funds New World R5E
OSPAX8.660.05
+0.58%
Invesco SteelPath MLP Alpha R6
RMBMX13.790.08
+0.58%
RMB SMID Cap I
GQERX23.650.11
+0.47%
GQG Partners US Select Quality Eq R6

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
+1.65%
VCYT - GH
52%
Loosely correlated
-0.39%
NVCR - GH
45%
Loosely correlated
+1.24%
TWST - GH
43%
Loosely correlated
+1.29%
BLFS - GH
41%
Loosely correlated
+0.86%
MASS - GH
40%
Loosely correlated
+0.57%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with MASS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+1.24%
MASS - NVCR
49%
Loosely correlated
+0.57%
GH - NVCR
45%
Loosely correlated
+1.65%
KIDS - NVCR
43%
Loosely correlated
+1.13%
VCYT - NVCR
43%
Loosely correlated
-0.39%
TWST - NVCR
43%
Loosely correlated
+1.29%
More